BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2894165)

  • 1. A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients.
    Fillastre JP; Letac B; Galinier F; Le Bihan G; Schwartz J
    Am J Cardiol; 1988 Feb; 61(7):81D-85D. PubMed ID: 2894165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and acceptability of rilmenidine for mild to moderate systemic hypertension.
    Ostermann G; Brisgand B; Schmitt J; Fillastre JP
    Am J Cardiol; 1988 Feb; 61(7):76D-80D. PubMed ID: 2894164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive efficacy and acceptability of rilmenidine in elderly hypertensive patients.
    Galley P; Manciet G; Hessel JL; Michel JP
    Am J Cardiol; 1988 Feb; 61(7):86D-90D. PubMed ID: 2894166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of rilmenidine for arterial hypertension.
    Beau B; Mahieux F; Paraire M; Laurin S; Brisgand B; Vitou P
    Am J Cardiol; 1988 Feb; 61(7):95D-102D. PubMed ID: 2894168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of systemic hypertension in insulin-treated diabetes mellitus with rilmenidine.
    Mpoy M; Vandeleene B; Ketelslegers JM; Lambert AE
    Am J Cardiol; 1988 Feb; 61(7):91D-94D. PubMed ID: 2894167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and acceptability of rilmenidine in mild to moderate arterial hypertension. A multicenter, randomized, double-blind trial, in comparison with methyldopa in 157 patients].
    Wilkinson R; Mansy S; Corcoran C
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():31-8. PubMed ID: 2517007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multicenter, double-blind study comparing rilmenidine 1 mg and hydrochlorothiazide 25 mg in 244 patients].
    Fiorentini C; Guillet C; Guazzi M
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():39-46. PubMed ID: 2517008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rilmenidine, a new antihypertensive agent in the first line treatment of essential arterial hypertension. Multicenter double-blind study versus atenolol].
    Dallocchio M; Gosse P; Fillastre JP; Grollier G; Morand P; Drici M; Corcoran C
    Presse Med; 1991 Aug 31-Sep 7; 20(27):1265-71. PubMed ID: 1832761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of two centrally-acting anti-hypertensive drugs on the quality of life.
    Fletcher AE; Beevers DG; Dollery CT; Wilkinson R; Bulpitt CJ
    Eur J Clin Pharmacol; 1991; 41(5):397-400. PubMed ID: 1684749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of rilmenidine and atenolol on mental stress, dynamic exercise and autonomic function in mild to moderate hypertension.
    Panfilov V; Morris AD; Donnelly R; Scemama M; Reid JL
    Br J Clin Pharmacol; 1995 Dec; 40(6):563-9. PubMed ID: 8703663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of rilmenidine in elderly patients--comparison with hydrochlorothiazide. The Belgian Multicentre Study Group.
    Pelemans W; Verhaeghe J; Creytens G; Coupez G; Van Dessel A; Opsomer M; Corcoran C
    Am J Cardiol; 1994 Dec; 74(13):51A-57A. PubMed ID: 7998586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rilmenidine: a novel approach to first-line treatment of hypertension.
    Laurent S; Safar M
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):99S-105S. PubMed ID: 1350733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of rilmenidine and atenolol on tests of autonomic function and mental and dynamic exercise in patients with essential hypertension.
    Panfilov V; Morris AD; Donnelly R; Reid JL
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S44-7. PubMed ID: 8642805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and tolerance of rilmenidine in patients with mild to moderate hypertension. Results of a Czech and Slovak 6-month multicenter study].
    Widimský J
    Vnitr Lek; 2002 Aug; 48(8):724-9. PubMed ID: 12425202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive study of cardiac structure and function after rilmenidine for essential hypertension.
    N'guyen van Cao A; Levy B; Slama R
    Am J Cardiol; 1988 Feb; 61(7):72D-75D. PubMed ID: 2894163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of rilmenidine on the central nervous system and kidney].
    Fillastre JP
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():19-23. PubMed ID: 2517005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome.
    Anichkov DA; Shostak NA; Schastnaya OV
    Curr Med Res Opin; 2005 Jan; 21(1):113-9. PubMed ID: 15881482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
    Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term control of blood pressure by rilmenidine in high-risk populations.
    Pillion G; Fevrier B; Codis P; Schutz D
    Am J Cardiol; 1994 Dec; 74(13):58A-65A. PubMed ID: 7998587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effort blood pressure control in the course of antihypertensive treatment.
    de Divitiis O; Di Somma S; Liguori V; Petitto M; Magnotta C; Ausiello M; Natale N; Brignoli M; Galderisi M
    Am J Med; 1989 Sep; 87(3C):46S-56S. PubMed ID: 2782327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.